U.S. Pharma Stock News

If you are wondering whether Pfizer at a last close of US$26.53 still offers solid value, the starting point is understanding what that price really implies about the business. Over the last year the stock returned 24.9%, with a 5.4% gain year to date, a 1.0% rise over the past week, and a 4.7% decline across the last 30 days, which signals that expectations and perceived risk have been shifting recently. Recent headlines have focused on Pfizer's efforts to reshape its portfolio and...

Global Net Lease (GNL) opened 2026 with Q1 revenue of US$109.3 million and basic EPS of a US$0.09 loss per share, keeping investors focused on how the income statement is tracking against past quarters. The company has seen quarterly revenue move from US$137.8 million in Q4 2024 to US$132.4 million in Q1 2025, then to US$124.9 million, US$121.0 million and US$117.0 million through 2025, alongside basic EPS that has ranged between a loss of US$0.46 per share and a profit of US$0.19 per share...

Fabrinet (FN) has just posted Q3 2026 results with revenue of US$1.2 billion, basic EPS of US$3.49 and net income of US$125.2 million, against a backdrop of 29% reported earnings growth over the last year and a trailing 12 month earnings growth rate of 19.2% per year over the past five years. The company has seen revenue move from US$871.8 million in Q3 2025 through US$909.7 million in Q4 2025 and US$978.1 million in Q1 2026 to US$1.2 billion in Q3 2026. Over the same span, basic EPS has gone...

Astera Labs (ALAB) has put up another active quarter, with Q1 2026 revenue of US$308.4 million and basic EPS of US$0.47, at a time when trailing 12 month EPS sits at US$1.59 on revenue of about US$1.0 billion and net income of US$267.6 million. This comes alongside very large year on year earnings growth and higher profit margins over the past year. Over the last five reported quarters, revenue has moved from US$159.4 million in Q1 2025 to US$308.4 million in Q1 2026, while quarterly EPS has...

Jacobs Solutions (J) opened Q2 2026 with revenue of about US$3.7b and a basic EPS loss of US$0.32, putting a negative earnings print alongside a higher top line. The company has seen quarterly revenue move from about US$2.9b in Q2 2025 to about US$3.7b in Q2 2026, while basic EPS shifted from US$0.10 in Q2 2025 to a loss of US$0.32 this quarter, setting up a mixed read on growth versus profitability that puts the spotlight firmly on margins and earnings quality. See our full analysis for...

Gulfport Energy (GPOR) opened 2026 with Q1 revenue of US$453.3 million and basic EPS of US$8.94, setting the tone for what the latest results say about margins and pricing across its portfolio. Over recent quarters, revenue has moved from US$338.1 million in Q1 2025 to US$350.1 million in Q4 2025 and now US$453.3 million in Q1 2026, while basic EPS has shifted from a small loss of US$0.07 in Q1 2025 to US$6.90 in Q4 2025 and US$8.94 in the latest quarter. With trailing twelve month EPS at...

Marqeta (MQ) has just posted its Q1 2026 scorecard, reporting revenue of US$165.8 million and basic EPS of US$0.02, with the trailing twelve months showing total revenue of US$651.6 million and basic EPS of US$0.00. Over recent quarters, revenue has ranged from US$135.8 million in Q4 2024 to US$172.1 million in Q4 2025, while quarterly basic EPS has moved from a loss of US$0.05 in Q4 2024 to a profit of US$0.02 in Q1 2026. This sets up a results season in which the key question for investors...

CF Bankshares (CFBK) opened 2026 with Q1 total revenue of about US$14.2 million and basic EPS of roughly US$0.77, set against trailing 12 month revenue of about US$53.4 million and EPS of roughly US$2.79 that reflect 22.8% earnings growth over the past year. Over recent periods, the company has seen quarterly revenue move from about US$13.5 million in Q1 2025 to roughly US$14.2 million in Q1 2026, while basic EPS shifted from about US$0.68 to roughly US$0.77, supported by trailing net profit...

In the first quarter of 2026, Balchem Corporation reported higher sales of US$270.71 million and net income of US$40.29 million, alongside completing a share repurchase of 159,539 shares for US$25.85 million under its December 2025 buyback program. The combination of earnings growth and active capital returns signals management’s focus on both expanding the business and returning excess cash to shareholders. We’ll now examine how Balchem’s stronger earnings and completed buyback program...

Edgewell Personal Care (EPC) has put fresh numbers on the table for Q2 2026, reporting revenue of US$519.5 million and basic EPS of US$0.09. This comes against a backdrop of trailing 12 month revenue of US$2.2 billion and a basic EPS loss of US$0.23. Over the past few quarters the company has seen revenue move between US$415.1 million and US$627.2 million, while basic EPS has swung from a loss of US$0.66 to a profit of US$0.62. This performance sets the scene for investors to focus on how...

Sinclair (SBGI) has drawn fresh attention after recent price moves, with the stock up about 12% over the past month and roughly 8% in the past 3 months, compared with a modest 1-year total return. See our latest analysis for Sinclair. The recent 30 day share price return of 11.67% and 90 day share price return of 8.25% contrast with a modest 1.14% 1 year total shareholder return, which suggests that momentum has increased only in the shorter term. If Sinclair's moves have your attention, it...

Belden Inc. has reported past first-quarter 2026 results, with sales rising to US$696.38 million and GAAP diluted EPS from continuing operations at US$1.30, and has also issued second-quarter 2026 guidance for revenues of US$735 million to US$750 million and GAAP EPS of US$1.53 to US$1.63. Together with progress on its Joseph C. Belden Innovation Award finalists, these figures highlight how Belden is pairing earnings stability with initiatives that promote IT/OT convergence and data-driven...

California Resources (CRC) opened 2026 with Q1 revenue of US$967 million and a basic EPS loss of US$8.02 per share, setting a stark headline for the latest quarter. The company has seen quarterly revenue move between US$798 million and US$926 million over the last year, while EPS shifted from a profit of US$1.93 in Q2 2025 to smaller profits in subsequent quarters before this latest loss. This leaves investors weighing solid top line scale against pressure on margins. See our full analysis...

Ingredion (NYSE:INGR) plans to cease operations at its Cabo manufacturing facility in Brazil by 2026. The company is experiencing operational challenges at its Argo facility, contributing to higher costs. Management reduced full year earnings guidance in response to these operational issues. Ingredion, a key supplier of ingredient solutions for food, beverage, and industrial customers, is reshaping its manufacturing footprint while dealing with disruptions at a core US site. The Cabo...

Concentrix (CNXC) is back in focus after its fiscal Q1 2026 earnings. Solid revenue growth contrasted with a sharp drop in operating and net income, prompting a strong market and analyst reaction. See our latest analysis for Concentrix. The Q1 earnings miss and a 6,000,000 share secondary sale by a large shareholder have coincided with sharp weakness. The 30 day share price return of 13.68% and the 1 year total shareholder return decline of 51.2% signal fading momentum after a longer period...

MasterBrand (MBC) opened Q1 2026 with revenue of US$618 million and a basic EPS loss of US$0.12, while trailing 12 month figures show revenue of about US$2.7 billion and a marginal basic EPS loss of US$0.02, underscoring pressure on profitability. Over recent quarters the company has seen revenue move between US$660.3 million in Q1 2025 and US$730.9 million in Q2 2025, alongside basic EPS shifting from a profit of US$0.29 in Q2 2025 to a loss of US$0.33 in Q4 2025. This sets the stage for...

SoundHound AI (NasdaqGM:SOUN) has introduced OASYS, a self-learning orchestrated agentic AI platform for enterprises. OASYS autonomously builds, manages, and improves multilingual AI agents across digital and physical channels. The platform is designed to handle complex workflows and incorporates technology from recent acquisitions. OASYS aims to move enterprise AI from a static build and deploy model to a continuously self-improving system. For investors tracking enterprise AI, OASYS...

In late April 2026, nine Hood County property owners filed a lawsuit against MARA Holdings over its Granbury, Texas bitcoin mine, alleging constant noise, vibrations, health impacts, and property value losses, and seeking damages reported to be up to US$10,000,000. The case is the fourth legal action targeting the same facility in under two years, spotlighting how community and environmental concerns can shape the operating outlook for large-scale digital asset infrastructure. We’ll now...

Citigroup is holding its first Investor Day in four years today, where senior leaders are expected to outline new profitability targets, AI deployment plans, and updates on risk-management remediation and capital returns. This rare investor forum offers a consolidated view of how management intends to balance technology investment, operational efficiency, and shareholder returns across the global franchise. We’ll now look at how the Investor Day focus on higher profitability targets and AI...

Veracyte (VCYT) just posted Q1 2026 results with revenue of US$139.1 million and basic EPS of US$0.36, while trailing 12 month figures show revenue of US$541.7 million and basic EPS of US$1.11, alongside a 166.3% year over year earnings increase and net margins at 16.2% versus 7.1% a year earlier. Over recent quarters the company has seen revenue move from US$114.5 million in Q1 2025 to US$139.1 million in Q1 2026, with basic EPS ranging from US$0.09 to US$0.52 in interim periods. This sets...

Jazz Pharmaceuticals (JAZZ) opened 2026 with Q1 revenue of US$1.1 billion and basic EPS of US$4.74, setting a clear marker against last year’s volatile run of quarterly results. Over recent quarters the company has seen revenue move from US$897.8 million in Q1 2025 to US$1.09 billion in Q4 2024 and then to US$1.07 billion in Q4 2025. Basic EPS has shifted from a loss of US$1.52 per share in Q1 2025 to US$3.16 in Q4 2024 and US$3.33 in Q4 2025, leaving investors focused on how much of the...

Deluxe (DLX) opened 2026 with Q1 revenue of US$538.1 million and basic EPS of US$0.77. Trailing 12 month figures show revenue of US$2.1 billion and EPS of US$2.31, supported by 85.5% earnings growth over the past year. Over recent quarters the company has seen revenue fluctuate in a tight band between US$520.6 million and US$540.2 million, with basic EPS ranging from US$0.26 to US$0.77, and net profit margins over the last 12 months running at 4.9% versus 2.6% in the prior year. This sets up...

If you are wondering whether L3Harris Technologies at around US$302 a share looks expensive or attractive, the next step is to line that price up against what the business might reasonably be worth. The stock has seen a 6.0% decline over the last 7 days and a 15.8% decline over the last 30 days, even though the 1 year return sits at 41.0% and the 3 year return at 70.1%. Recent headlines have focused on L3Harris Technologies as a key player in aerospace and defense programs and contract...

Vontier (NYSE:VNT) highlighted its multi energy fleet technology strategy at ACT Expo 2026. The company presented an integrated platform that combines traditional and new energy refueling, EV management, diagnostics, payment security, and telematics. The event showcased new solutions aimed at supporting fleet decarbonization and digital transformation. For investors tracking the fleet and mobility sector, Vontier sits at the intersection of hardware, software, and services for...